# Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study

> **NCT02642419** · PHASE4 · UNKNOWN · sponsor: **Japan Cardiovascular Research Foundation** · enrollment: 2200 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel)
- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT02642419
- **Lead sponsor:** Japan Cardiovascular Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2015-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642419, "Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02642419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*